| Secondary hyperparathyroidism. Conservative management in patients with renal insufficiency. | |
| | |
MedLine Citation:
|
PMID: 1173103 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
In three patients with advanced renal disease (inulin clearance, 4.6 to 9.1 ml/min) and systemic manifestations of secondary hyperparathyroidism, concentrations of serum calcium and phosphorus were maintained within our normal limits (9 and 3.5 mg/100 ml, respectively) with phosphate-binding antacids and orally given calcium carbonate. The result was progressive disappearance of symptoms related to secondary hyperparathyroidism, healing of osteitis fibrosa, and normalization of serum concentrations of immunoreactive parathyroid hormone. |
| | |
Authors:
|
M M Popovtzer; W F Pinggera; J B Robinette |
Related Documents
:
|
19117833 - Effect of bimonthly supplementation with oral cholecalciferol on serum 25-hydroxyvitami... 1398473 - Serum osteocalcin levels do not change during rapidly induced hypercalcemia in healthy ... 6911763 - The effects of progesterone on glucose and lactate metabolism in ovariectomized sheep. |
Publication Detail:
|
Type: Journal Article; Research Support, U.S. Gov't, P.H.S. |
Journal Detail:
|
Title: JAMA : the journal of the American Medical Association Volume: 231 ISSN: 0098-7484 ISO Abbreviation: JAMA Publication Date: 1975 Mar |
Date Detail:
|
Created Date: 1975-07-01 Completed Date: 1975-07-01 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 7501160 Medline TA: JAMA Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 960-2 Citation Subset: AIM; IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Administration, Oral Adult Antacids / therapeutic use* Calcium / administration & dosage, blood, therapeutic use* Carbonates / administration & dosage, therapeutic use Female Humans Hyperparathyroidism, Secondary / complications, drug therapy* Inulin / diagnostic use Kidney Failure, Chronic / complications* Male Middle Aged Osteitis Fibrosa Cystica / drug therapy Parathyroid Hormone / blood, immunology Phosphates / blood |
| Chemical | |
Reg. No./Substance:
|
0/Antacids; 0/Carbonates; 0/Parathyroid Hormone; 0/Phosphates; 7440-70-2/Calcium; 9005-80-5/Inulin |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Sickle cell crisis treated by exchange transfusion. Treatment of two patients with heterozygous sick...
Next Document: Infarction of breast fibroadenomas during pregnancy.